Anaphylaxis is a severe and generalized form of hypersensitivity or allergic reaction. It can be life-threatening and requires rapid management. Cases of anaphylaxis are growing worldwide. The first line treatment in anaphylaxis is epinephrine. However, despite guidelines emphasizing the importance of this drug, studies show that use of epinephrine in anaphylaxis is suboptimal. In this article we describe the practical approach to recognizing and managing anaphylaxis in various settings.
Citation: Maria Wołos, Jan Stachurski. The role of epinephrine in anaphylaxis at all stages of management in pediatric populations[J]. AIMS Medical Science, 2021, 8(2): 80-86. doi: 10.3934/medsci.2021009
Anaphylaxis is a severe and generalized form of hypersensitivity or allergic reaction. It can be life-threatening and requires rapid management. Cases of anaphylaxis are growing worldwide. The first line treatment in anaphylaxis is epinephrine. However, despite guidelines emphasizing the importance of this drug, studies show that use of epinephrine in anaphylaxis is suboptimal. In this article we describe the practical approach to recognizing and managing anaphylaxis in various settings.
| [1] |
Cardona V, Ansotegui IJ, Ebisawa M, et al. (2020) World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 13: 100472. doi: 10.1016/j.waojou.2020.100472
|
| [2] |
Sicherer SH, Simons FER (2017) Epinephrine for first-aid management of anaphylaxis. Pediatrics 139: e20164006. doi: 10.1542/peds.2016-4006
|
| [3] |
Rudders SA, Banerji A, Clark S, et al. (2011) Age-related differences in the clinical presentation of food-induced anaphylaxis. J Pediatr 158: 326-328. doi: 10.1016/j.jpeds.2010.10.017
|
| [4] |
Simons FE, Sampson HA (2015) Anaphylaxis: unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol 135: 1125-1131. doi: 10.1016/j.jaci.2014.09.014
|
| [5] |
Turner PJ, Jerschow E, Umasunthar T, et al. (2017) Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract 5: 1169-1178. doi: 10.1016/j.jaip.2017.06.031
|
| [6] |
Turner PJ, Gowland MH, Sharma V, et al. (2015) Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol 135: 956-963.e1. doi: 10.1016/j.jaci.2014.10.021
|
| [7] |
Motosue MS, Bellolio MF, Van Houten HK, et al. (2018) Outcomes of emergency department anaphylaxis visits from 2005 to 2014. J Allergy Clin Immunol Pract 6: 1002-1009.e2. doi: 10.1016/j.jaip.2017.07.041
|
| [8] | Emergency treatment of anaphylactic reactions: guidelines for healthcare providers Working Group of the Resuscitation Council (UK) (2016) .Available from: https://www.resus.org.uk/sites/default/files/2020-06/EmergencyTreatmentOfAnaphylacticReactions%20%281%29.pdf. |
| [9] |
Brown JC, Simons E, Rudders SA (2020) Epinephrine in the management of anaphylaxis. J Allergy Clin Immunol Pract 8: 1186-1195. doi: 10.1016/j.jaip.2019.12.015
|
| [10] |
Fleming JT, Clark S, Camargo CA, et al. (2015) Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract 3: 57-62. doi: 10.1016/j.jaip.2014.07.004
|
| [11] |
Cardona V, Ferré-Ybarz L, Guilarte M, et al. (2017) Safety of adrenaline use in anaphylaxis: a multicentre register. Int Arch Allergy Immunol 173: 171-177. doi: 10.1159/000477566
|
| [12] |
Anagnostou K (2018) Anaphylaxis in children: epidemiology, risk factors and management. Curr Pediatr Rev 14: 180-186. doi: 10.2174/1573396314666180507115115
|
| [13] |
Grabenhenrich LB, Dölle S, Ruëff F, et al. (2018) Epinephrine in severe allergic reactions: the european anaphylaxis register. J Allergy Clin Immunol Pract 6: 1898-1906.e1. doi: 10.1016/j.jaip.2018.02.026
|
| [14] |
Brown JC (2018) Epinephrine, auto-injectors, and anaphylaxis: challenges of dose, depth, and device. Ann Allergy Asthma Immunol 121: 53-60. doi: 10.1016/j.anai.2018.05.001
|
| [15] |
Edwards E, Kessler C, Cherne N, et al. (2018) Human factors engineering validation study for a novel 0.1-mg epinephrine auto-injector. Allergy Asthma Proc 39: 461-465. doi: 10.2500/aap.2018.39.4171
|
| [16] |
Lieberman P, Nicklas RA, Randolph C, et al. (2015) Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol 115: 341-384. doi: 10.1016/j.anai.2015.07.019
|
| [17] |
Simons KJ, Simons FE (2010) Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol 10: 354-361. doi: 10.1097/ACI.0b013e32833bc670
|
| [18] |
Choi YJ, Kim J, Jung JY (2019) Underuse of epinephrine for pediatric anaphylaxis victims in the emergency department: a population-based study. Allergy Asthma Immunol Res 11: 529-537. doi: 10.4168/aair.2019.11.4.529
|
| [19] |
Prince BT, Mikhail I, Stukus DR (2018) Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. J Asthma Allergy 11: 143-151. doi: 10.2147/JAA.S159400
|
| [20] |
Cristiano LM, Hiestand B, Caldwell JW, et al. (2018) Prehospital administration of epinephrine in pediatric anaphylaxis—a statewide perspective. Prehosp Emerg Care 22: 452-456. doi: 10.1080/10903127.2017.1399184
|
| [21] |
Carrillo E, Hern HG, Barger J (2016) Prehospital administration of epinephrine in pediatric anaphylaxis. Prehosp Emerg Care 20: 239-244. doi: 10.3109/10903127.2015.1086843
|
| [22] |
Dubus JC, Lê MS, Vitte J, et al. (2019) Use of epinephrine in emergency department depends on anaphylaxis severity in children. Eur J Pediatr 178: 69-75. doi: 10.1007/s00431-018-3246-3
|
| [23] |
Song TT, Brown D, Karjalainen M, et al. (2018) Value of a second dose of epinephrine during anaphylaxis: a patient/caregiver survey. J Allergy Clin Immunol Pract 6: 1559-1567. doi: 10.1016/j.jaip.2018.01.019
|
Maria Wołos, Jan Stachurski. The role of epinephrine in anaphylaxis at all stages of management in pediatric populations[J]. AIMS Medical Science, 2021, 8(2): 80-86. doi: 10.3934/medsci.2021009
DownLoad: